Please login to the form below

Not currently logged in

Lilly go public on HCP partnership payments

Eli Lilly has launched an online 'faculty registry' providing details of payments made to US physicians and other healthcare professionals

Eli Lilly has launched an online 'faculty registry' which provides details of the payments the company has made to US physicians and other healthcare professionals during the first quarter of 2009.

The website also gives details of the professional's name, location, a description of the services provided, and explains Lilly's policy on creating partnerships with physicians and other healthcare experts on patient education, healthcare professional education, advising and consulting. Details of the payments the company makes to physicians and other healthcare professionals will be updated quarterly.

"This registry is consistent with Lilly's efforts to increase transparency," said Jack Harris, MD and vice president of Lilly's US medical division. "We see greater transparency as integral to rebuilding trust in our industry." The company states that entries in the registry have either advised Lilly or conducted medical lectures designed for healthcare professionals and patient education.

In February, Lilly entered into a Corporate Integrity Agreement with the Office of the Inspector General of the US Department of Health and Human Services and was required to disclose the information.

Previously, in 2004 Lilly became the first company to voluntarily make public its clinical trials. In 2007, Lilly added another first by publicly reporting all of its educational grants and charitable contributions.

The faculty registry is at

3rd August 2009


Featured jobs

Subscribe to our email news alerts


Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...